HB 236 extends the required blood testing window for combat sports athletes in Maryland from 30 days to 90 days. It affects boxers, kickboxers, wrestlers, and mixed martial arts competitors seeking licenses or participating in contests. The bill mandates that applicants and licensed contestants must provide documented evidence of negative tests for HIV, hepatitis B, and hepatitis C within 90 days prior to license application or competition. This change modifies existing Maryland law (Sections 4-101 and 4-304.1 of the Business Regulation Article) to align testing timing with the State Athletic Commission's requirements. The bill takes effect October 1, 2026.
SB 88 creates a limited license for music therapists in Maryland who are completing full licensure requirements. It allows the State Board of Examiners to issue these licenses to applicants who meet education standards (including American Music Therapy Association certification), pay fees, and practice under supervision of a fully licensed music therapist. The limited license is valid for one year, renewable once, but expires if full licensure isn't obtained within two years. This does not replace existing services by audiologists or speech-language pathologists, and the practice of music therapy is defined as using music-based interventions within a therapeutic relationship. The bill directly affects aspiring music therapists seeking licensure and the State Board of Examiners.
HB 7 authorizes Maryland's State Board of Examiners to issue limited licenses for music therapists who are completing full licensing requirements but lack sufficient clinical experience. This directly affects new music therapists and healthcare facilities needing to hire them under supervision while they fulfill certification steps. The bill creates a 1-year limited license (renewable once) requiring direct supervision by a fully licensed music therapist, with a 2-year deadline to obtain full licensure. It explicitly states limited licenses cannot replace services from audiologists or speech-language pathologists. The policy change streamlines entry into the profession without altering existing practice standards for music therapy.
SB 272 requires health insurance plans that cover chemotherapy for cancer treatment to also cover scalp cooling systems. These systems are devices designed to prevent or reduce hair loss during chemotherapy by cooling the scalp. The law applies to insurers, nonprofit health service plans, health maintenance organizations, and managed care organizations offering such coverage in Maryland. It takes effect for all policies issued, delivered, or renewed on or after January 1, 2027.
SB 333 creates the Interstate Podiatric Medical Licensure Compact, allowing podiatrists (foot and ankle specialists) licensed in Maryland to practice in other participating states more easily. The bill establishes a streamlined process for obtaining an "expedited license" in multiple states without altering existing state licensing laws, requiring podiatrists to pass national exams and pass background checks. Crucially, it mandates that podiatrists follow the rules of the state where the patient is located during treatment, not where the provider is licensed. This compact directly affects licensed podiatrists seeking multi-state practice and state licensing boards overseeing medical practice.
SB 293 requires nursing homes, assisted living facilities, and nurse midwives to notify residents and prospective residents in writing if they lack professional liability insurance or if coverage has lapsed without renewal. For prospective residents, notification must occur at the first visit during a coverage gap or at the time of application; current residents must be notified within 30 days of a lapse. Facilities without coverage must also post a conspicuous notice visible to residents and guests. This law aims to increase transparency about insurance coverage for individuals receiving care in these settings.
SB 444 repeals an exemption that previously allowed intermediate care facilities offering substance use disorder treatment to change bed capacity without a certificate of need. It creates a new exemption for facilities providing *medically managed residential substance use disorder treatment services*, removing the requirement for a certificate of need if they submit 45 days' written notice to the Commission and the Commission determines the change aligns with the state health plan, improves service efficiency, and serves the public interest. This bill directly affects intermediate care facilities focused on substance use disorder treatment by reducing regulatory barriers for expanding bed capacity or establishing new facilities. The key mechanism is replacing a certificate of need with a streamlined notice-and-review process administered by the Commission. (SB 444, "Certificate of Need - Intermediate Health Care Facilities," 2026)
HB 1445, the "Maryland Protecting People With Disabilities Act," changes eligibility rules for home- and community-based services under Maryland's Medicaid program (Maryland Medical Assistance Program). It requires the state to continue services uninterrupted during appeals if an individual loses eligibility, prohibits automatic termination solely due to administrative errors (procedural disenrollment), and mandates data sharing between providers and the Department of Health. The bill directly affects people receiving Developmental Disabilities Administration services and Medicaid beneficiaries who risk losing community-based care due to eligibility disputes. Key provisions include extending appeal timelines (replacing 90-day deadlines with continuous service until appeal resolution) and requiring the state to reserve waiver slots for those who lost eligibility unfairly. These changes aim to align with the Olmstead v. L.C. Supreme Court ruling protecting community integration rights.
HB 1117 requires Maryland's Medicaid program (Maryland Medical Assistance Program) and certain insurers to cover approved "elopement response devices" for specific individuals. These devices - such as door sensors, wearable location trackers, or alert systems - prevent people with cognitive, developmental, or neurological conditions from wandering unsafely (e.g., leaving a supervised area without the ability to return safely). Coverage is mandated when ordered by a qualified healthcare provider and documented in a qualifying plan (like an individualized education plan or dementia care plan) for eligible recipients: those under 21 with early screening eligibility, on home-based waiver programs, or diagnosed with Alzheimer’s/dementia. The bill defines these devices as medical equipment or assistive technology under state programs, ensuring coverage without regard to when the program was established.
HB 1292 requires child advocacy centers in Maryland to ensure all health care professionals providing medical or mental health services are properly licensed or certified and work within their scope of practice. It mandates that centers establish a "continuity of care plan" to notify families when providers change, including contact information for both new and former providers, and allows former providers to assist with care transitions per professional standards. Centers must report specific violations to health occupations boards or the Governor’s Office of Crime Prevention and Policy, and the Governor’s Office must publish annual data about child advocacy centers online. This bill directly affects child advocacy centers, their health care staff, and the children and families receiving services at these centers.